President Trump's administration reclassified state-licensed medical marijuana from Schedule I to Schedule III under the Controlled Substances Act through an order signed by Todd Blanche, representing the most significant federal cannabis policy shift in over 50 years. The reclassification affects medical marijuana programs in 40 states and grants licensed operators major tax breaks by allowing business expense deductions for the first time, while establishing an expedited DEA registration system. The order does not legalize marijuana federally and maintains Schedule I classification for cannabis outside state medical programs, while the Trump administration has scheduled a hearing for late June to consider broader marijuana reclassification. The policy change follows a Biden administration proposal that drew nearly 43,000 public comments, though more than 20 Republican senators had urged Trump to maintain current classification standards.
Apr 7, 2026 · 1 source
Apr 6, 2026 · 1 source
Apr 3, 2026 · 2 sources
Mar 31, 2026 · 1 source
Story comments
Loading comments…